MicroRNA-599 regulates the development of Parkinson’s disease through mediating LRRK2 expression
Q. Wu, D.-Z. Xi, Y.-H. Wang Department of Rehabilitation Medicine, Shanxi Provincial People’s Hospital, Taiyuan, China. liyujun-wuqin@163.com
OBJECTIVE: This study investigates whether microRNA-599 can inhibit the progression of Parkinson’s disease (PD) by regulating the LRRK2 expression. We aim to search for a new therapeutic target for PD.
MATERIALS AND METHODS: A mouse model of PD was first established. A relative amount of TH+ neurons in the mouse brain was quantified by immunohistochemistry. The expression levels of microRNA-599 and LRRK2 in mouse brain tissues were determined by the quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) and Western blot. Cell model of PD was constructed by MPP+ treatment in SH-SY5Y cells. The expression levels of microRNA-599 and LRRK2 in MPP+-induced SH-SY5Y cells were examined as well. We verified the binding condition between microRNA-599 and LRRK2 through dual-luciferase reporter gene assay. The viability and apoptosis in MPP+-induced SH-SY5Y cells overexpressing microRNA-599 were determined by cell counting kit-8 (CCK-8) assay and flow cytometry, respectively.
RESULTS: Compared with normal mice, TH+ neurons were fewer in the brain tissue of PD mice. MicroRNA-599 expression was lower, while LRRK2 expression was higher in brain tissues of PD mice relative to controls. Meanwhile, in vitro expression of microRNA-599 was downregulated and LRRK2 expression was upregulated in MPP+-induced SH-SY5Y cells. Dual-luciferase reporter gene assay verified the binding condition between microRNA-599 and LRRK2. The microRNA-599 overexpression downregulated the LRRK2 expression in SH-SY5Y cells, and conversely, the microRNA-599 knockdown upregulated the LRRK2 expression. Of note, the microRNA-599 overexpression protected MPP+-induced viability decrease and apoptosis acceleration in SH-SY5Y cells.
CONCLUSIONS: MicroRNA-599 is lowly expressed in both in vivo and in vitro PD model. MicroRNA-599 inhibits the development of PD through regulating the LRRK2 expression.
Free PDF DownloadThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
Q. Wu, D.-Z. Xi, Y.-H. Wang
MicroRNA-599 regulates the development of Parkinson’s disease through mediating LRRK2 expression
Eur Rev Med Pharmacol Sci
Year: 2019
Vol. 23 - N. 2
Pages: 724-731
DOI: 10.26355/eurrev_201901_16886